IJC Heart & Vasculature,
Journal Year:
2024,
Volume and Issue:
54, P. 101482 - 101482
Published: Aug. 2, 2024
Cardiovascular
complications
of
COVID-19
are
numerous
and
aspects
this
phenomenon
not
well
known.
The
main
objective
manuscript
is
a
systematic
review
the
acute
chronic
cardiovascular
secondary
to
COVID-19.
A
literature
through
Medline
via
PubMed
was
conducted
(2020-2024).
There
plethora
effects
on
heart
in
setting.
Here
we
discuss
pathophysiology,
myocardial
infarctions,
failure,
Takotsubo
Cardiomyopathy,
injury,
myocarditis
arrhythmias
that
caused
by
Additionally,
these
injuries
can
linger
may
be
an
underlying
cause
some
Long
COVID
symptoms.
life-threatening.
affect
health.
Microclotting
induced
SARS-CoV-2
infection
could
therapeutic
target
for
Covid.
Tropical Medicine and Health,
Journal Year:
2025,
Volume and Issue:
53(1)
Published: Jan. 14, 2025
Abstract
Background
Vietnam
experienced
the
first
COVID-19
domestic
outbreak
due
to
Wuhan
strain
(B.1.1)
in
Da
Nang
from
July
2020.
can
cause
acute
as
well
long-term
health
problems.
We
aimed
characterise
clinical
features
and
risk
factors
related
severe
illness
of
among
cases
describe
outcomes
survivors
this
outbreak.
Methods
conducted
an
ambidirectional
cohort
study.
Study
subjects
were
all
hospitalised
with
positive
real-time
PCR
test
SARS-CoV-2
three
major
hospitals
25
28
August
Clinical
demographic
information
was
retrospectively
collected
medical
charts.
Then,
followed-up
prospectively
at
6
16
months
after
infection
assess
their
status
via
standardized
questionnaires,
physical
examinations,
chest
X-rays
pulmonary
function
tests.
Results
A
total
362
including
20
fatal
enrolled
into
study
retrospectively.
The
median
age
participants
included
chart
review
46.5
years
60.8%
female.
Overall,
7.8%
required
respiratory
support
during
hospitalisation
them
died.
Compared
survivors,
significantly
older
(median
45.0
yr
vs
66.5
yr,
P
<
0.001)
more
likely
have
underlying
conditions.
proportions
who
had
least
one
long
COVID
symptom
within
7
days
each
follow-up
72.0%
(134/186)
63.5%
(47/74),
respectively.
also
found
that
females
adults
reported
symptoms
often
surveys,
78.9%
(90/114)
[females]
61.1%
(44/72)
[males]
months,
=
0.008;
68.7%
(46/67)
[
$$\ge$$
≥
years]
14.3%
(1/7)
$$[<$$
[<
0.004.
Conclusions
In
Vietnam,
mortality
rate
approximately
6%
associated
a
substantial
proportion
problems,
although
prevalence
declined
over
time.
Females
often,
which
might
be
pathophysiological
differences
according
sex
age.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
SUMMARY
Post-acute
sequelae
of
COVID-19
(PASC)
is
a
complex
and
multifaceted
clinical
challenge
requiring
to
emphasize
its
underlying
pathophysiological
mechanisms.
This
study
assessed
hundreds
virological,
serological,
immunological,
tissue
damage
biomarkers
in
two
patient
cohorts
who
experienced
mild
(n=270)
or
severe
(n=188)
COVID-19,
6
9
months
post-initial
infection,
which
40%
57.4%
patients,
respectively,
developed
PASC.
Blood
analysis
showed
that
mains
differences
observed
humoral,
viral,
biological
were
associated
with
the
initial
severity,
rather
than
being
specifically
linked
However,
patients
PASC
displayed
altered
CD4
+
CD8
memory
T-cell
subsets,
higher
cytokine-secreting
cells
increased
terminally
differentiated
CD45RA
effector
T
(TEMRA).
Elevated
SARS-CoV-2-specific
responsive
nucleocapsid/membrane
proteins
TEMRA
phenotype
also
observed.
A
random
forest
model
identified
these
features
symptom
duration
as
top
variables
discriminating
PASC,
achieving
over
80%
classification
accuracy.
Highlights
Nine
SARS-CoV-2
Regardless
disease
form
influenced
main
immune
led
subsets
elevated
presence
form,
count
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 26, 2025
Animal
models
are
indispensable
for
unraveling
the
mechanisms
underlying
post-acute
sequelae
of
COVID-19
(PASC).
This
review
evaluates
recent
research
on
PASC-related
perturbations
in
animal
models,
drawing
comparisons
with
clinical
findings.
Despite
limited
number
studies
post-COVID
conditions,
particularly
those
extending
beyond
three
months,
these
provide
valuable
insights.
Three
hallmark
features
PASC-lung
fibrosis,
hyperglycemia,
and
neurological
sequelae-have
been
successfully
replicated
paving
way
mechanistic
discoveries
future
medical
interventions.
Although
most
have
reported
conditions
within
14-60
days
post-infection,
they
still
offer
critical
reference
long-term
research.
also
explores
potential
persisting
immune
misfiring,
a
key
factor
chronicity
PASC
symptoms.
Moreover,
challenges
modeling
discussed,
including
genetic
diversity
inbred
strains
difficulties
accurately
identifying
PASC-affected
individuals.
To
address
issues,
we
propose
methodological
improvements,
such
as
comparing
individual
parameters
control
averages
incorporating
genetically
diverse
populations
like
collaborative
cross
models.
These
strategies
will
enhance
identification
characterization
endotypes
studies.
By
integrating
findings
from
manifestations
PASC,
can
more
insights
into
its
support
development
effective
therapeutic
strategies.
Finally,
emphasize
urgent
need
longitudinal
to
fully
uncover
driving
guide
interventions
mitigate
public
health
impact.
Abstract
Long
coronavirus
disease
(COVID)
is
defined
as
the
continuation
or
development
of
new
symptoms
three
months
after
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection,
and
that
last
for
at
least
two
months,
with
no
other
explanation
their
cause.
This
includes
various
clinical
manifestations
affect
multiple
organ
systems,
such
complications
in
respiratory,
cardiovascular,
neurological,
musculoskeletal
systems.
The
most
commonly
reported
include
fatigue,
cognitive
dysfunction,
dyspnea,
chest
pain;
however,
prevalence
severity
these
vary
greatly
among
individuals.
underlying
mechanisms
long
COVID
are
complex
multifaceted,
encompassing
viral
persistence,
immune
system
mitochondrial
abnormalities,
endothelial
impairment,
alterations
microbiome.
Further,
has
imposed
a
significant
burden
on
individuals,
healthcare
economy
by
impairing
an
individual’s
quality
life
functional
capacity,
thereby
increasing
costs
demand
care
rehabilitation
services.
review
summarizes
definition,
phenotypes,
mechanisms,
current
treatment
advancements
highlights
specific
research
directions
future
investigation.
Memórias do Instituto Oswaldo Cruz,
Journal Year:
2025,
Volume and Issue:
120
Published: Jan. 1, 2025
Coronavirus
disease
2019
(COVID-19)
is
caused
by
the
new
coronavirus
2
(severe
acute
respiratory
syndrome
-
SARS-CoV-2).
Long
COVID
a
condition
associated
with
persistent
COVID-19
symptoms
and/or
emerging
symptoms.
Telomeres
are
specialised
structures
for
genome
protection
at
end
of
chromosomes
and
telomerase
enzyme
that
synthesises
telomere
DNA.
Patients
were
recruited
Pedro
Ernesto
University
Hospital
(HUPE)
in
Rio
de
Janeiro,
Brazil,
main
purpose
investigating
association
between
length
COVID.
Leukocyte
(LTL)
was
determined
quantitative
real-time
polymerase
chain
reaction
(qPCR)
34
patients
compared
to
control
group
(n
=
122).
Telomerase
activity
qPCR
assays
using
commercial
kit
from
ScienCell.
A
questionnaire
on
symptoms,
vaccine
doses
blood
count
completed.
The
found
have
an
increase
LTL.
also
examined
smaller
number
be
reactivated
blood.
It
will
necessary
conduct
further
studies
monitor
determine
if
future
health
issues
could
linked
elongated
telomeres.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Background
Despite
the
efficacy
of
SARS-CoV-2
vaccines
in
reducing
mortality
and
severe
cases
COVID-19,
a
proportion
survivors
experience
long-term
symptoms,
known
as
post-acute
sequelae
infection
(PASC).
This
study
investigates
immunological
neurodegenerative
effects
associated
with
extracellular
vesicles
(EVs)
COVID-19
survivors,
15
months
after
infection.
Methods
13
Controls
20
infection,
were
recruited.
Pro-inflammatory
cytokines
analyzed
both
plasma
EVs.
A
deep-immunophenotyping
monocytes,
T-cells
dendritic
cells
(DCs)
was
performed,
along
immunostainings
colon.
Results
Higher
concentrations
pro-inflammatory
neurofilaments
found
EVs
but
not
from
survivors.
Additionally,
participants
exhibited
altered
monocyte
activation
markers
elevated
cytokine
production
upon
lipopolysaccharide
stimulation.
Increased
CD4+
decreased
indoleamine
2,3-dioxygenase
expression
DCs
observed
participants.
Furthermore,
amount
plasmacytoid
DCs9
expressing
β7-integrin
higher
potentially
viral
persistence
Conclusions
exhibit
immune
dysregulation
neurodegeneration,
emphasizing
need
for
ongoing
monitoring
PASC.
The
cargo
can
be
promising
tool
early
detection
virus-induced
neurological
disorders.